Survivin products in pituitary tumors

Neuroendocrinology Letters

Volumn 29, Issue 6, 2008, Pages 1033-1037

  Jankowska, Arma ^a   Wasko, Ryszard ^a   Waligorska Stachura, Joanna ^a   Andrusiewicz, Miroslaw ^a   Jaskula, Magdalena ^a   Liebert, Wlodzimierz ^a   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Pituitary tumors; Survivin expression

Indexed keywords

MESSENGER RNA; SURVIVIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 59849116772     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Deveraux QL, Reed JC. (1999). IAP family proteins-suppressors of apoptosis. Genes Dev. 13; 239-252.
2. LaCasse EC et al. (1998). The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17; 3247-3259.
3. Li F et al. (1998). Control of apoptosis and mitotic spindle check-point by survivin. Nature.396; 580-584.
4. Ambrosini G et al. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3; 917-921.
5. Altieri DC (2001). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med. 7;542-547.
6. Ambrosini G et al. (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem. 273; 11177-82.
7. Takai N et al. (2002). Survivin expression correlates with clinical stage, histological grade, invasive behavior, and survival rate in endometrial carcinoma. Cancer Lett. 184; 105-116.
8. Ikeguchi M et al. (2202). Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol. 11; 33-40.
9. Altieri DC. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 22; 8581-9.
10. Hassounah M et al. (2005). Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis. J NeuroOncol. 72; 203-208.
11. Cohen C et al. (2003). Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod Pathol. 16; 574-583.
12. Monzo M et al. (1999). A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers. J Clin Oncol. 17; 2100-2104.
13. Kato J et al. (2001). Expression of survivin in esophageal cancer: correlation with the prognosis response to chemiotherapy. Int J Cnancer. 95; 92-95.
14. Grabowski P et al. (2003). Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer. 88; 115-119.
15. Kappler M. (2001). Increased survivin transcript levels; an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer. 95; 360-363.
16. Azuhata T et al. (2001). The inhibitor of apoptosis protein survivin is associated with high risk behavior of neuroblastoma. J Pediatr Surg. 36; 1785-1791.
17. Arafah BM, Nasrallah MP. (2001). Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 8: 287-305.
18. Wasko R et al. (2005). Survivin expression in pituitary adenomas. Neuroendocrinol Lett. 26; 209-12.
19. Duffy MJ et al. (2007). Survivin: a promisisng tumor biomarker. Cancer Lett. 249: 49-60.
20. Velculescu VE et al. (1999). Analysisof human transcriptomes. Nat Genet. 23: 387-8.
21. Li F et al. (2005). Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer. 114; 509-12.
22. Okada E et al. (2001). Survivin expression in tumors cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 163: 109-16..
23. Crispen PL et al. (2008). Predicting disease progression after nephrectomy for localized renal cell carcinoma: The utility of prognostic models and molecular biomarkers. Cancer 3.
24. Chen T, Deng C. (2008). Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. Int Immunopharmacol. 8; 1006-11.
25. Tsuruma T et al. (2008). Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer. J Transl Med. 6: 24.